TF and colonic neoplasm: TF factors including ISX (suppressed ~ 2.3 fc in both), contain these binding motifs, suggesting an observed loss of these site-specific TFs might dictate de-novo hypermethylation and suppression of its downstream targets, in a side independent manner within colon cancers.